Showing results (11-20 of 26) with videos related to
Sort By:
Pageof 3
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 22, 2025
Risk Factors Associated with Gastroenteropancreatic and Lung Neuroendocrine Tumors: A Nested Case-Control Study from The All of Us Research ProgramTao Xu, Joseph S Dillon, Dawn E Quelle, et al.International Journal of Cancer|January 21, 2012
Toenail trace element status and risk of Barrett's oesophagus and oesophageal adenocarcinoma: results from the FINBAR studyMichael A O'Rorke, Marie M Cantwell, Christian C Abnet, et al.European Journal of Cancer (Oxford, England : 1990)|November 14, 2012
Do perinatal and early life exposures influence the risk of malignant melanoma? A Northern Ireland birth cohort analysisM A O'Rorke, C Black, L J Murray, et al.Leukemia & Lymphoma|June 26, 2025
Changes in first-line treatment patterns according to frailty in chronic lymphocytic leukemia/small lymphocytic lymphomaVanessa E Slater, Ryan M Carnahan, Christopher S Strouse, et al.Cancer Causes & Control : CCC|August 31, 2013
Non-steroidal anti-inflammatory drug use and brain tumour risk: a case-control study within the Clinical Practice Research DatalinkF J Bannon, M A O'Rorke, L J Murray, et al.Cancer Epidemiology|September 18, 2013
Non-steroidal anti-inflammatory drug use and cervical cancer risk: a case-control study using the Clinical Practice Research DatalinkJ C Wilson, M A O'Rorke, J A Cooper, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 24, 2014
Prior autoimmune disease and risk of monoclonal gammopathy of undetermined significance and multiple myeloma: a systematic reviewCharlene M McShane, Liam J Murray, Ola Landgren, et al.American Journal of Clinical Oncology|August 3, 2021
Impact of Surgeon Type and Rurality on Treatment and Survival of Ovarian Cancer PatientsKristin S Weeks, Charles F Lynch, Michele M West, et al.Journal of Cancer Research and Clinical Oncology|November 3, 2024
Peptide Receptor Radionuclide Therapy and clinical associations with renal and hematological toxicities and survival in patients with neuroendocrine tumors: an analysis from two U.S. medical centersTao Xu, Joseph S Dillon, Mary A Maluccio, et al.Journal of the American Heart Association|December 1, 2022
Cardiac Adverse Events Associated With Chemo-Radiation Versus Chemotherapy for Resectable Stage III Non-Small-Cell Lung Cancer: A Surveillance, Epidemiology and End Results-Medicare StudyEmma Herbach, Michael A O'Rorke, Ryan M Carnahan, et al.Pageof 3